Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24 studies found for:    "Coal workers pneumoconiosis"
Show Display Options
Rank Status Study
1 Not yet recruiting Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis
Condition: Pneumoconiosis
Intervention: Biological: Human umbilical cord mesenchymal stem cells
2 Recruiting A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells
Condition: Pneumoconiosis
Interventions: Procedure: large volume whole-lung lavage (WLL);   Biological: clinical grade umbilical cord mesenchymal stem cells
3 Completed Specialized Center of Research in Occupational and Immunologic Lung Disease
Conditions: Lung Diseases, Obstructive;   Asbestosis;   Silicosis;   Pneumoconiosis;   Chronic Obstructive Pulmonary Disease
4 Recruiting Comprehensive Risk Assessment of People With Silicosis: A Population-based Study
Condition: Silicosis
Intervention: Other: People with silicosis
5 Not yet recruiting Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Conditions: Lung Transplant;   Lung Resection;   Lung Cancer;   Asthma;   Cystic Fibrosis;   Chronic Obstructive Pulmonary Disease;   Emphysema;   Mesothelioma;   Asbestosis;   Pulmonary Embolism;   Interstitial Lung Disease;   Pulmonary Fibrosis;   Bronchiectasis;   Seasonal Allergies;   Cold Virus;   Lung Infection;   Pulmonary Hypertension;   Pulmonary Dysplasia;   Obstructive Sleep Apnea
Interventions: Drug: HP 3He;   Drug: HP 129Xe;   Drug: PFP;   Drug: SF6;   Device: 129Xe Small and Large Human Lung Coil;   Device: 3He Human Lung Coil;   Device: PFP and SF6 Human Lung Coil
6 Recruiting Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)
Condition: Chronic Beryllium Disease
Intervention: Other: Nothing
7 Recruiting The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)
Conditions: Chronic Beryllium Disease (CBD);   Beryllium Sensitization (BeS)
Interventions: Procedure: Blood draw;   Procedure: bronchoscopy
8 Recruiting Evaluation of Myocardial Iron Deposition in Patients of Heart Failure Using T2* MR Imaging
Conditions: Heart Failure;   Iron Overload;   Cardiomyopathies
Intervention: Other: MR T2* imaging
9 Recruiting Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention
Conditions: Silicosis;   Tuberculosis
Intervention: Drug: Weekly INH / RRT given by DOT
10 Recruiting Oscillation Mechanics of the Respiratory System Asbestos Exposed: Early Diagnosis
Condition: Asbestosis
Intervention: Other: evaluated lung function
11 Completed Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis
Condition: Silicosis
Intervention: Other: Cells
12 Active, not recruiting Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
Conditions: Intracerebral Hemorrhage;   Cerebral Amyloid Angiopathy;   Ischemic Stroke
13 Completed
Has Results
An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)
Condition: Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia
Intervention: Device: MRI scan
14 Completed Oscillation Mechanics of the Respiratory System in Never-smoking Patients With Silicosis
Condition: Silicosis
15 Unknown  Oxidative Stress Biomarkers to Monitor and Early Detect Health Impairment in Workers Exposed to Silica (Caesar Stone)
Condition: Silicosis
16 Unknown  DNA-damage Pathways in Workers Exposed to Silica (Caesar Stone)
Condition: Silicosis
17 Active, not recruiting Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis
Condition: Superficial Siderosis
18 Completed Safety of Stem Cells Intrabronchial Instillation for Silicosis
Condition: Chronic and Accelerated Silicosis
Intervention: Other: Autologous cell transplantation
19 Unknown  Assessment of Iron Deposition in Major Organs of Hemodialysis Patients
Condition: Iron Overload
20 Completed Targeting Oxidative Stress in Chronic Beryllium Disease
Condition: Chronic Beryllium Disease
Interventions: Drug: Mesalamine;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Indicates status has not been verified in more than two years